compounded semaglutide crackdown news today FDA Intensifies on GLP-1 Compounding The FDA is proposing the

All injectable peptides are temperature-sensitive

The effects of these modified versions on the human body remain uncertain, as they have not been studied in clinical trials

About 15% maintained most of their loss

Key takeaways: GLP-1 medications are primarily used for weight loss, but are increasingly being explored in relation to PCOS and perimenopause Early evidence (mainly in women with obesity and PCOS) suggests GLP-1s may improve insulin resistance and support more regular menstrual cycles and ovulation There is currently limited research on how GLP-1 medications affect periods, fertility, PMS, or menopause symptoms in the wider population Period tracking apps like Clue may help users monitor cycle and symptom changes while using GLP-1 medications 1